Artal Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-502,899
| Closed | -$11.7M | – | 28 |
|
|
2024
Q2 | $11.7M | Hold |
502,899
| – | – | 0.3% | 37 |
|
|
2024
Q1 | $10.3M | Sell |
502,899
-300,000
| -37% | -$5.64M | 0.27% | 45 |
|
|
2023
Q4 | $17.2M | Hold |
802,899
| – | – | 0.59% | 25 |
|
|
2023
Q3 | $16.6M | Hold |
802,899
| – | – | 0.72% | 23 |
|
|
2023
Q2 | $23.7M | Hold |
802,899
| – | – | 0.76% | 19 |
|
|
2023
Q1 | $18.5M | Buy |
802,899
+2,899
| +0.4% | +$79.8K | 1.1% | 23 |
|
|
2022
Q4 | $22.2M | Buy |
800,000
+200,000
| +33% | +$5.95M | 1.28% | 25 |
|
|
2022
Q3 | $18.4M | Hold |
600,000
| – | – | 0.96% | 29 |
|
|
2022
Q2 | $17.7M | Hold |
600,000
| – | – | 0.98% | 29 |
|
|
2022
Q1 | $19.3M | Hold |
600,000
| – | – | 0.82% | 30 |
|
|
2021
Q4 | $26.8M | Buy |
600,000
+100,000
| +20% | +$4.74M | 0.79% | 34 |
|
|
2021
Q3 | $25.2M | Hold |
500,000
| – | – | 0.62% | 44 |
|
|
2021
Q2 | $39.2M | Hold |
500,000
| – | – | 0.89% | 27 |
|
|
2021
Q1 | $28.6M | Buy |
500,000
+100,000
| +25% | +$6.69M | 0.6% | 47 |
|
|
2020
Q4 | $33.5M | Hold |
400,000
| – | – | 0.77% | 38 |
|
|
2020
Q3 | $14.3M | Sell |
400,000
-50,000
| -11% | -$1.51M | 0.47% | 63 |
|
|
2020
Q2 | $10.9M | Sell |
450,000
-50,000
| -10% | -$1.18M | 0.37% | 67 |
|
|
2020
Q1 | $8.76M | Buy |
500,000
+100,000
| +25% | +$2.09M | 0.42% | 52 |
|
|
2019
Q4 | $6.97M | Hold |
400,000
| – | – | 0.29% | 63 |
|
|
2019
Q3 | $6.13M | Hold |
400,000
| – | – | 0.3% | 67 |
|
|
2019
Q2 | $8.3M | Hold |
400,000
| – | – | 0.38% | 58 |
|
|
2019
Q1 | $9.29M | Sell |
400,000
-100,000
| -20% | -$2.09M | 0.44% | 55 |
|
|
2018
Q4 | $10.3M | Hold |
500,000
| – | – | 0.51% | 42 |
|
|
2018
Q3 | $10.9M | Hold |
500,000
| – | – | 0.38% | 50 |
|
|
2018
Q2 | $7.63M | Buy |
500,000
+50,000
| +11% | +$942K | 0.2% | 56 |
|
|
2018
Q1 | $8.86M | Sell |
450,000
-50,000
| -10% | -$1.03M | 0.13% | 52 |
|
|
2017
Q4 | $7.82M | Buy |
+500,000
| New | +$8.99M | 0.15% | 53 |
|
Other funds holding DNLI
CM
